Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fuji
Teva
Mallinckrodt
Harvard Business School
Johnson and Johnson
Cerilliant
Federal Trade Commission
Julphar
Dow

Generated: June 24, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 208223

« Back to Dashboard

NDA 208223 describes ZEMBRACE SYMTOUCH, which is a drug marketed by Dr Reddys Labs Ltd and is included in one NDA. It is available from one supplier. Additional details are available on the ZEMBRACE SYMTOUCH profile page.

The generic ingredient in ZEMBRACE SYMTOUCH is sumatriptan succinate. There are twenty-four drug master file entries for this compound. Forty-six suppliers are listed for this compound. Additional details are available on the sumatriptan succinate profile page.
Summary for 208223
Tradename:ZEMBRACE SYMTOUCH
Applicant:Dr Reddys Labs Ltd
Ingredient:sumatriptan succinate
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 208223
Suppliers and Packaging for NDA: 208223
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ZEMBRACE SYMTOUCH sumatriptan succinate SOLUTION;SUBCUTANEOUS 208223 NDA Promius Pharma, LLC 67857-809 N 67857-809-38

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:SOLUTION;SUBCUTANEOUSStrengthEQ 3MG BASE/0.5ML (EQ 3MG BASE/0.5ML)
Approval Date:Jan 28, 2016TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
Citi
McKinsey
Baxter
Dow
Federal Trade Commission
Moodys
Boehringer Ingelheim
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.